Showing results (31-40 of 162) with videos related to
Sort By:
Pageof 17
Drug Safety|March 24, 2005
Hepatic findings in long-term clinical trials of ximelagatranWilliam M Lee, Dominique Larrey, Rolf Olsson, et al.JHEP Reports : Innovation in Hepatology|May 4, 2023
Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohortLina Hountondji, Christophe Ferreira De Matos, Fanny Lebossé, et al.The Annals of Pharmacotherapy|November 22, 2013
Acute hepatitis and renal failure related to intranasal buprenorphine misuse: case report and analysis of cases reported to the French network for drug monitoringCéline Eiden, Marie-Pierre Ripault, Dominique Larrey, et al.Antiviral Therapy|May 22, 2012
Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirinDominique Larrey, Christophe Carenco, Dominique Guyader, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2023
Cholangitis Induced by Immune Checkpoint Inhibitors: Analysis of Pharmacovigilance DataLucy Meunier, Lina Hountondji, Hélène Jantzem, et al.Annals of Hepatology|April 29, 2004
Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trialDiego García-Compean, Pierre Blanc, Dominique Larrey, et al.Digestive Diseases (Basel, Switzerland)|November 27, 2019
Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory ApproachesGerald Holtmann, Dietmar Schrenk, Ahmed Madisch, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2025
Features and Outcomes of 280 Patients With Idiosyncratic Drug-induced Liver Injury: The REFHEPS Prospective StudyLucy Meunier, Bénédicte Delire, Eleonora De Martin, et al.Journal of Virology|July 23, 2002
Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitroValérie Castet, Chantal Fournier, Alexandre Soulier, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 8, 2025
Ursodeoxycholic Acid Alone Is Effective and Safe to Treat Cholestatic Checkpoint Inhibitor-Induced Liver InjuryLina Hountondji, Stéphanie Faure, Pascale Palassin, et al.Pageof 17